2024-05-20 00:11:59,521 - root - INFO - Logging setup complete.
2024-05-20 00:11:59,521 - root - INFO - Configuration loaded.
2024-05-20 00:11:59,960 - root - INFO - WebDriver setup complete.
2024-05-20 00:11:59,974 - root - INFO - Checking https://www.crownbio.com/model-systems/in-vitro/organoids for NLP analysis...
2024-05-20 00:12:02,756 - root - INFO - URL: https://www.crownbio.com/model-systems/in-vitro/organoids
2024-05-20 00:12:02,756 - root - INFO - 
=== Text Sentences ===
2024-05-20 00:12:02,756 - root - INFO - We Value Your PrivacyThis website stores cookies on your computer.
2024-05-20 00:12:02,756 - root - INFO - These cookies are used to collect information about how you interact with our website and allow us to remember you.
2024-05-20 00:12:02,757 - root - INFO - We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media.
2024-05-20 00:12:02,757 - root - INFO - To find out more about the cookies we use, see our Privacy Policy
If you decline, your information won’t be tracked when you visit this website.
2024-05-20 00:12:02,757 - root - INFO - A single cookie will be used in your browser to remember your preference not to be tracked.

2024-05-20 00:12:02,757 - root - INFO - Cookies and Tracking settings
Accept
Decline
Contact Us
Databases
CrownLink
Search
English
Services
About Us
Our Science
MODEL SYSTEMS
IN VITRO
ORGANOIDS
Organoids for Oncology Drug Development
Preclinical oncology drug development and validation services using tumor organoids and the HUB tumor organoid biobank.

2024-05-20 00:12:02,757 - root - INFO - Progress Oncology Drug Development with Organoids Developed using HUB Protocols
  Make use of the great translatability of our 3D organoid models which show unprecedented patient response predictivity.
2024-05-20 00:12:02,757 - root - INFO - Benefit from faster development and enhanced scalability of organoids.
2024-05-20 00:12:02,757 - root - INFO - Model and mirror patient population diversity via screening multiple tumor organoid models simultaneously, and access both tumor and healthy organoids to evaluate in vitro data with clinically relevant drug potency and efficacy as well as off target effects.

2024-05-20 00:12:02,757 - root - INFO - FEATURES
APPLICATIONS
STUDY OPTIONS
Features
 Proprietary culture methods: Highly refined culture methods developed using Clevers Lab HUB’s protocols via exclusive partnerships, providing proprietary services
Varied indications: Multiple organoids available for over 20 organ and tissue types
Amenable to genetic perturbation via gene editing techniques such as RNA interference or CRISPR/Cas to identify and validate biological targets and discover mechanistic biomarkers
Maximizing the efficiency of the organoid platform with powerful imaging technology to penetrate the 3D structure and visualize the dynamic interplay of cells and their response to drug candidates.
  
2024-05-20 00:12:02,757 - root - INFO - Matched models: Paired in vitro PDXO and in vivo PDX models provide improved predictivity and a more rapid and informed study transition
Clinically relevant models:
2024-05-20 00:12:02,757 - root - INFO - Harnessing ASCs either directly from patients (PDOs) or from xenograft tissue (PDXOs) to recapitulate the complex architecture of in vivo tissue.
2024-05-20 00:12:02,757 - root - INFO - Unlimited expansion for large-scale screens
Living biobanks: Organoid database which includes light microscopy, genomic, transcriptomic, and pharmacology data

2024-05-20 00:12:02,757 - root - INFO - Integrated radiotherapy capabilities: Drug-Radiation combination testing using organoids
  Organoid Applications
Drug discovery and development:
2024-05-20 00:12:02,757 - root - INFO - Test candidate efficacy, safety, side effects, and pharmacokinetic properties as well as mechanism of action
Safety and toxicity studies: Evaluate safety and toxicity profiles using healthy organoids, developed from non-transformed cells
Personalized medicine: Leverage HUB OrganoidsTM as patient epitomes to design targeted and personalized therapies and stratify your patient population
Disease modeling: Capture disease relevance and patient population heterogeneity
Bridging in vitro and in vivo: Identify your target patient population before entering the clinical trails
Predictive biomarker identification: Determine potential biomarkers of therapeutic response with companion diagnostics
  Study Options
Preclinical oncology drug development and validation services using unique organoid models developed using IP-protected Hubrecht Organoid Technology (HUB) protocols, as well as HUB’s biobank of already established patient-derived organoids (PDOs)
Large-scale screens and drug radiation: Select models, and evaluate efficacy and multi-drug combination strategies
Efficacy and viability quantification: Identify responder and non-responder tumor models.
2024-05-20 00:12:02,757 - root - INFO - Leverage high content services to produce highly comprehensive morphology readouts in both 2D and 3D models.
2024-05-20 00:12:02,758 - root - INFO - Use multifactorial data for downstream lead ID and decision-making
HCI-based phenotype screening: Phenotypical screen up to thousands of compounds.
2024-05-20 00:12:02,758 - root - INFO - Layer and score drug effects with image mediated screens
Immunotherapy assessment: Benefit from the only immuno- oncology platform incorporating patient-relevant 3D in vitro models co-cultured with non-autologous immune cells
OrganoidXplore:
2024-05-20 00:12:02,758 - root - INFO - The first large-scale, panel based organoid screening service
OrganoidBase™
 

High Content Services
  Immunology
  Request a quote
Crown Bioscience needs the contact information you provide to us to contact you about our products and services.
2024-05-20 00:12:02,758 - root - INFO - You may unsubscribe from these communications at anytime.

2024-05-20 00:12:02,758 - root - INFO - For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

2024-05-20 00:12:02,758 - root - INFO - In Vitro
2D Cell Lines and Panels
PDX-Derived Cell Lines: PrimePanel™
2D HuCell™
CRISPR/Cas9 Gene Editing
Organoids
Organoid and Immune Cell Co-Culture

2024-05-20 00:12:02,758 - root - INFO - In Vivo
Blog Post
Advancing Cancer Drug Discovery with Exclusive Organoid Technology Using Adult Stem Cells
READ NOW
Application Note
Drug Discovery in 3D
DOWNLOAD NOW
White Paper
When and How to Use Tumor Organoids in Drug Discovery
DOWNLOAD NOW

2024-05-20 00:12:02,758 - root - INFO - © 2024 Crown Bioscience.

2024-05-20 00:12:02,758 - root - INFO - Terms of Use
Privacy Statement
   
2024-05-20 00:12:02,758 - root - INFO - 
=== Named Entities ===
2024-05-20 00:12:02,758 - root - INFO - Cookies (ORG)
2024-05-20 00:12:02,758 - root - INFO - Accept
Decline
Contact Us
Databases (PERSON)
2024-05-20 00:12:02,758 - root - INFO - Us (GPE)
2024-05-20 00:12:02,758 - root - INFO - Our Science
MODEL SYSTEMS (WORK_OF_ART)
2024-05-20 00:12:02,758 - root - INFO - HUB (ORG)
2024-05-20 00:12:02,758 - root - INFO - Progress Oncology Drug Development (ORG)
2024-05-20 00:12:02,758 - root - INFO - FEATURES (PRODUCT)
2024-05-20 00:12:02,758 - root - INFO - Clevers Lab HUB (WORK_OF_ART)
2024-05-20 00:12:02,758 - root - INFO - Varied (ORG)
2024-05-20 00:12:02,758 - root - INFO - over 20 (CARDINAL)
2024-05-20 00:12:02,758 - root - INFO - RNA (ORG)
2024-05-20 00:12:02,758 - root - INFO - CRISPR (PERSON)
2024-05-20 00:12:02,758 - root - INFO - PDX (ORG)
2024-05-20 00:12:02,758 - root - INFO - Organoid (GPE)
2024-05-20 00:12:02,758 - root - INFO - Integrated (NORP)
2024-05-20 00:12:02,758 - root - INFO - Evaluate (ORG)
2024-05-20 00:12:02,758 - root - INFO - Bridging (ORG)
2024-05-20 00:12:02,758 - root - INFO - IP (ORG)
2024-05-20 00:12:02,758 - root - INFO - Hubrecht Organoid Technology (ORG)
2024-05-20 00:12:02,758 - root - INFO - HUB (ORG)
2024-05-20 00:12:02,758 - root - INFO - HUB (ORG)
2024-05-20 00:12:02,758 - root - INFO - Efficacy (ORG)
2024-05-20 00:12:02,758 - root - INFO - Identify (ORG)
2024-05-20 00:12:02,758 - root - INFO - 2D (ORG)
2024-05-20 00:12:02,758 - root - INFO - HCI (GPE)
2024-05-20 00:12:02,758 - root - INFO - up to thousands (CARDINAL)
2024-05-20 00:12:02,758 - root - INFO - OrganoidXplore (ORG)
2024-05-20 00:12:02,759 - root - INFO - first (ORDINAL)
2024-05-20 00:12:02,759 - root - INFO - Crown Bioscience (PRODUCT)
2024-05-20 00:12:02,759 - root - INFO - Privacy Policy (ORG)
2024-05-20 00:12:02,759 - root - INFO - Vitro (PRODUCT)
2024-05-20 00:12:02,759 - root - INFO - 2D Cell Lines (ORG)
2024-05-20 00:12:02,759 - root - INFO - PrimePanel (ORG)
2024-05-20 00:12:02,759 - root - INFO - HuCell (ORG)
2024-05-20 00:12:02,759 - root - INFO - Organoid (ORG)
2024-05-20 00:12:02,759 - root - INFO - Immune Cell Co-Culture (ORG)
2024-05-20 00:12:02,759 - root - INFO - Exclusive Organoid Technology Using Adult Stem Cells (ORG)
2024-05-20 00:12:02,759 - root - INFO - Application Note
Drug Discovery (WORK_OF_ART)
2024-05-20 00:12:02,759 - root - INFO - DOWNLOAD (ORG)
2024-05-20 00:12:02,759 - root - INFO - Discovery (PRODUCT)
2024-05-20 00:12:02,759 - root - INFO - DOWNLOAD (ORG)
2024-05-20 00:12:02,759 - root - INFO - 2024 (CARDINAL)
2024-05-20 00:12:02,759 - root - INFO - 
=== Keywords ===
2024-05-20 00:12:02,759 - root - INFO - We
2024-05-20 00:12:02,759 - root - INFO - cookies
2024-05-20 00:12:02,759 - root - INFO - your computer
2024-05-20 00:12:02,759 - root - INFO - These cookies
2024-05-20 00:12:02,759 - root - INFO - information
2024-05-20 00:12:02,759 - root - INFO - you
2024-05-20 00:12:02,759 - root - INFO - our website
2024-05-20 00:12:02,759 - root - INFO - us
2024-05-20 00:12:02,759 - root - INFO - you
2024-05-20 00:12:02,759 - root - INFO - We
2024-05-20 00:12:02,759 - root - INFO - this information
2024-05-20 00:12:02,759 - root - INFO - order
2024-05-20 00:12:02,759 - root - INFO - your browsing experience
2024-05-20 00:12:02,759 - root - INFO - analytics
2024-05-20 00:12:02,759 - root - INFO - metrics
2024-05-20 00:12:02,759 - root - INFO - our visitors
2024-05-20 00:12:02,759 - root - INFO - this website
2024-05-20 00:12:02,759 - root - INFO - other media
2024-05-20 00:12:02,759 - root - INFO - the cookies
2024-05-20 00:12:02,759 - root - INFO - we
2024-05-20 00:12:02,759 - root - INFO - our Privacy Policy
2024-05-20 00:12:02,759 - root - INFO - you
2024-05-20 00:12:02,759 - root - INFO - your information
2024-05-20 00:12:02,759 - root - INFO - you
2024-05-20 00:12:02,759 - root - INFO - this website
2024-05-20 00:12:02,759 - root - INFO - A single cookie
2024-05-20 00:12:02,759 - root - INFO - your browser
2024-05-20 00:12:02,759 - root - INFO - your preference
2024-05-20 00:12:02,759 - root - INFO - Cookies and Tracking settings
2024-05-20 00:12:02,759 - root - INFO - Us
2024-05-20 00:12:02,759 - root - INFO - Oncology Drug Development
Preclinical oncology drug development
2024-05-20 00:12:02,759 - root - INFO - validation services
2024-05-20 00:12:02,759 - root - INFO - tumor organoids
2024-05-20 00:12:02,759 - root - INFO - the HUB tumor organoid biobank
2024-05-20 00:12:02,759 - root - INFO - Progress Oncology Drug Development
2024-05-20 00:12:02,759 - root - INFO - Organoids
2024-05-20 00:12:02,759 - root - INFO - HUB Protocols
2024-05-20 00:12:02,759 - root - INFO - use
2024-05-20 00:12:02,760 - root - INFO - the great translatability
2024-05-20 00:12:02,760 - root - INFO - our 3D organoid models
2024-05-20 00:12:02,760 - root - INFO - which
2024-05-20 00:12:02,760 - root - INFO - unprecedented patient response predictivity
2024-05-20 00:12:02,760 - root - INFO - faster development
2024-05-20 00:12:02,760 - root - INFO - enhanced scalability
2024-05-20 00:12:02,760 - root - INFO - organoids
2024-05-20 00:12:02,760 - root - INFO - Model and mirror patient population diversity
2024-05-20 00:12:02,760 - root - INFO - multiple tumor organoid models
2024-05-20 00:12:02,760 - root - INFO - both tumor
2024-05-20 00:12:02,760 - root - INFO - healthy organoids
2024-05-20 00:12:02,760 - root - INFO - vitro data
2024-05-20 00:12:02,760 - root - INFO - clinically relevant drug potency
2024-05-20 00:12:02,760 - root - INFO - efficacy
2024-05-20 00:12:02,760 - root - INFO - target effects
2024-05-20 00:12:02,760 - root - INFO - FEATURES
APPLICATIONS
STUDY OPTIONS
Features
 Proprietary culture methods
2024-05-20 00:12:02,760 - root - INFO - Highly refined culture methods
2024-05-20 00:12:02,760 - root - INFO - Clevers Lab HUB’s protocols
2024-05-20 00:12:02,760 - root - INFO - exclusive partnerships
2024-05-20 00:12:02,760 - root - INFO - proprietary services
Varied indications
2024-05-20 00:12:02,760 - root - INFO - Multiple organoids
2024-05-20 00:12:02,760 - root - INFO - over 20 organ and tissue types
2024-05-20 00:12:02,760 - root - INFO - genetic perturbation
2024-05-20 00:12:02,760 - root - INFO - techniques
2024-05-20 00:12:02,760 - root - INFO - RNA interference
2024-05-20 00:12:02,760 - root - INFO - CRISPR/Cas
2024-05-20 00:12:02,760 - root - INFO - biological targets
2024-05-20 00:12:02,760 - root - INFO - mechanistic biomarkers
2024-05-20 00:12:02,760 - root - INFO - the efficiency
2024-05-20 00:12:02,760 - root - INFO - the organoid platform
2024-05-20 00:12:02,760 - root - INFO - powerful imaging technology
2024-05-20 00:12:02,760 - root - INFO - the 3D structure
2024-05-20 00:12:02,760 - root - INFO - the dynamic interplay
2024-05-20 00:12:02,760 - root - INFO - cells
2024-05-20 00:12:02,760 - root - INFO - their response
2024-05-20 00:12:02,760 - root - INFO - drug candidates
2024-05-20 00:12:02,760 - root - INFO - Matched models
2024-05-20 00:12:02,760 - root - INFO - vitro PDXO
2024-05-20 00:12:02,760 - root - INFO - vivo PDX models
2024-05-20 00:12:02,760 - root - INFO - improved predictivity
2024-05-20 00:12:02,760 - root - INFO - relevant models
2024-05-20 00:12:02,760 - root - INFO - ASCs
2024-05-20 00:12:02,760 - root - INFO - patients
2024-05-20 00:12:02,760 - root - INFO - PDOs
2024-05-20 00:12:02,760 - root - INFO - xenograft tissue
2024-05-20 00:12:02,760 - root - INFO - PDXOs
2024-05-20 00:12:02,760 - root - INFO - the complex architecture
2024-05-20 00:12:02,760 - root - INFO - vivo tissue
2024-05-20 00:12:02,760 - root - INFO - Unlimited expansion
2024-05-20 00:12:02,760 - root - INFO - large-scale screens
2024-05-20 00:12:02,760 - root - INFO - Living biobanks
2024-05-20 00:12:02,760 - root - INFO - Organoid database
2024-05-20 00:12:02,760 - root - INFO - which
2024-05-20 00:12:02,761 - root - INFO - pharmacology
2024-05-20 00:12:02,761 - root - INFO - data
2024-05-20 00:12:02,761 - root - INFO - Integrated radiotherapy capabilities
2024-05-20 00:12:02,761 - root - INFO - Drug-Radiation combination testing
2024-05-20 00:12:02,761 - root - INFO - organoids
  Organoid Applications
Drug discovery
2024-05-20 00:12:02,761 - root - INFO - development
2024-05-20 00:12:02,761 - root - INFO - Test candidate efficacy
2024-05-20 00:12:02,761 - root - INFO - safety
2024-05-20 00:12:02,761 - root - INFO - side effects
2024-05-20 00:12:02,761 - root - INFO - pharmacokinetic properties
2024-05-20 00:12:02,761 - root - INFO - mechanism
2024-05-20 00:12:02,761 - root - INFO - action
Safety and toxicity studies
2024-05-20 00:12:02,761 - root - INFO - safety and toxicity profiles
2024-05-20 00:12:02,761 - root - INFO - healthy organoids
2024-05-20 00:12:02,761 - root - INFO - non-transformed cells
Personalized medicine
2024-05-20 00:12:02,761 - root - INFO - Leverage HUB
2024-05-20 00:12:02,761 - root - INFO - patient epitomes
2024-05-20 00:12:02,761 - root - INFO - targeted and personalized therapies
2024-05-20 00:12:02,761 - root - INFO - your patient population
Disease modeling
2024-05-20 00:12:02,761 - root - INFO - Capture disease relevance
2024-05-20 00:12:02,761 - root - INFO - patient population heterogeneity
Bridging
2024-05-20 00:12:02,761 - root - INFO - vivo
2024-05-20 00:12:02,761 - root - INFO - your target patient population
2024-05-20 00:12:02,761 - root - INFO - the clinical trails
Predictive biomarker identification
2024-05-20 00:12:02,761 - root - INFO - potential biomarkers
2024-05-20 00:12:02,761 - root - INFO - therapeutic response
2024-05-20 00:12:02,761 - root - INFO - companion diagnostics
  Study Options
Preclinical oncology drug development
2024-05-20 00:12:02,761 - root - INFO - validation services
2024-05-20 00:12:02,761 - root - INFO - unique organoid models
2024-05-20 00:12:02,761 - root - INFO - IP-protected Hubrecht Organoid Technology (HUB) protocols
2024-05-20 00:12:02,761 - root - INFO - HUB
2024-05-20 00:12:02,761 - root - INFO - already established patient-derived organoids
2024-05-20 00:12:02,761 - root - INFO - PDOs)
Large-scale screens
2024-05-20 00:12:02,761 - root - INFO - drug radiation
2024-05-20 00:12:02,761 - root - INFO - Select models
2024-05-20 00:12:02,761 - root - INFO - efficacy and multi-drug combination strategies
2024-05-20 00:12:02,761 - root - INFO - Efficacy
2024-05-20 00:12:02,761 - root - INFO - viability
2024-05-20 00:12:02,761 - root - INFO - quantification
2024-05-20 00:12:02,761 - root - INFO - responder
2024-05-20 00:12:02,761 - root - INFO - non-responder tumor models
2024-05-20 00:12:02,761 - root - INFO - high content services
2024-05-20 00:12:02,761 - root - INFO - highly comprehensive morphology readouts
2024-05-20 00:12:02,761 - root - INFO - both 2D and 3D models
2024-05-20 00:12:02,761 - root - INFO - multifactorial data
2024-05-20 00:12:02,761 - root - INFO - downstream lead ID
2024-05-20 00:12:02,761 - root - INFO - Phenotypical screen
2024-05-20 00:12:02,761 - root - INFO - thousands
2024-05-20 00:12:02,761 - root - INFO - compounds
2024-05-20 00:12:02,761 - root - INFO - Layer
2024-05-20 00:12:02,761 - root - INFO - score drug effects
2024-05-20 00:12:02,761 - root - INFO - image mediated screens
Immunotherapy assessment
2024-05-20 00:12:02,761 - root - INFO - the only immuno- oncology platform
2024-05-20 00:12:02,761 - root - INFO - patient-relevant 3D
2024-05-20 00:12:02,762 - root - INFO - vitro models
2024-05-20 00:12:02,762 - root - INFO - non-autologous immune cells
2024-05-20 00:12:02,762 - root - INFO - OrganoidXplore
2024-05-20 00:12:02,762 - root - INFO - screening service
OrganoidBase
2024-05-20 00:12:02,762 - root - INFO - a quote
Crown Bioscience
2024-05-20 00:12:02,762 - root - INFO - the contact information
2024-05-20 00:12:02,762 - root - INFO - you
2024-05-20 00:12:02,762 - root - INFO - us
2024-05-20 00:12:02,762 - root - INFO - you
2024-05-20 00:12:02,762 - root - INFO - our products
2024-05-20 00:12:02,762 - root - INFO - services
2024-05-20 00:12:02,762 - root - INFO - You
2024-05-20 00:12:02,762 - root - INFO - these communications
2024-05-20 00:12:02,762 - root - INFO - information
2024-05-20 00:12:02,762 - root - INFO - your privacy
2024-05-20 00:12:02,762 - root - INFO - our Privacy Policy
2024-05-20 00:12:02,762 - root - INFO - Vitro
2024-05-20 00:12:02,762 - root - INFO - 2D Cell Lines
2024-05-20 00:12:02,762 - root - INFO - Panels
2024-05-20 00:12:02,762 - root - INFO - PDX
2024-05-20 00:12:02,762 - root - INFO - -Derived Cell Lines
2024-05-20 00:12:02,762 - root - INFO - PrimePanel
2024-05-20 00:12:02,762 - root - INFO - 2D HuCell™
CRISPR/Cas9 Gene Editing
Organoids
Organoid
2024-05-20 00:12:02,762 - root - INFO - Immune Cell
2024-05-20 00:12:02,762 - root - INFO - Co
2024-05-20 00:12:02,762 - root - INFO - -
2024-05-20 00:12:02,762 - root - INFO - Culture
2024-05-20 00:12:02,762 - root - INFO - Blog Post
2024-05-20 00:12:02,762 - root - INFO - Exclusive Organoid Technology
2024-05-20 00:12:02,762 - root - INFO - Adult Stem Cells
2024-05-20 00:12:02,762 - root - INFO - NOW
Application Note
Drug Discovery
2024-05-20 00:12:02,762 - root - INFO - Tumor Organoids
2024-05-20 00:12:02,762 - root - INFO - Drug Discovery
2024-05-20 00:12:02,762 - root - INFO - DOWNLOAD
2024-05-20 00:12:02,762 - root - INFO - © 2024 Crown Bioscience
2024-05-20 00:12:02,762 - root - INFO - Terms
2024-05-20 00:12:02,762 - root - INFO - Use
Privacy Statement
2024-05-20 00:12:02,762 - root - INFO - 
=== Sentiment Analysis ===
2024-05-20 00:12:02,762 - root - INFO - {'neg': 0.026, 'neu': 0.884, 'pos': 0.091, 'compound': 0.9916}
2024-05-20 00:12:02,763 - root - INFO - NLP Report generated and saved to ./reports/www_crownbio_com_model_systems_in_vitro_organoids/nlp_analysis_20240520_001202.txt.
